SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/D0A68A4D110B1BC24E849D42BF840C4734E4B3F3CEA3CBC52BFC4B5173B845E165348FEA9153C27E9A4F39B204BAC4A8>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/D0A68A4D110B1BC24E849D42BF840C4734E4B3F3CEA3CBC52BFC4B5173B845E165348FEA9153C27E9A4F39B204BAC4A8
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/D0A68A4D110B1BC24E849D42BF840C4734E4B3F3CEA3CBC52BFC4B5173B845E165348FEA9153C27E9A4F39B204BAC4A8
http://www.w3.org/2000/01/rdf-schema#comment
"Blockade of either VEGF or its receptors with neutralizing antibodies significantly reduced cell viability and increased apoptosis levels of the VEGFR-positive thyroid tumour cell line."
xsd:string
http://purl.uniprot.org/uniprot/#_1650DCD2D74FEE72E095E13C61D0E29BB1EE56CA9EAB5A811CBA343F76E26D6D4F87EA92E94EA92632CBBC743728CF4D
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/D0A68A4D110B1BC24E849D42BF840C4734E4B3F3CEA3CBC52BFC4B5173B845E165348FEA9153C27E9A4F39B204BAC4A8
http://purl.uniprot.org/uniprot/B4DEK3
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D0A68A4D110B1BC24E849D42BF840C4734E4B3F3CEA3CBC52BFC4B5173B845E165348FEA9153C27E9A4F39B204BAC4A8
http://purl.uniprot.org/uniprot/#_B4DEK3-mappedCitation-16260429
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D0A68A4D110B1BC24E849D42BF840C4734E4B3F3CEA3CBC52BFC4B5173B845E165348FEA9153C27E9A4F39B204BAC4A8